Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term fluoxetine in chronic ischemic stroke
2006-005044-86Phase 2Active
- Sponsor
- Roessingh Research & Development
- Start
- Nov 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of fluoxetine in ischemic stroke, sponsored by Roessingh Research & Development. Primary endpoints: Brain excitability change, Muscle activation change and 1 more. Started Nov 2006; status: active.
02
Drugs
fluoxetine
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on 2006-005044-86.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-005044-86.